Literature DB >> 9455996

Characterization of adenosine receptors on rat ileum, ileal longitudinal muscle and muscularis mucosae.

J Nicholls1, S M Hourani.   

Abstract

Adenosine receptors were studied in isolated rat ileum, ileal longitudinal muscle and muscularis mucosae, using a range of agonists and an antagonist. In the rat ileal longitudinal muscle adenosine receptor agonists relaxed the tissues. N6-cyclopentyladenosine (CPA) was more potent than 5'-N-ethylcarboxamidoadenosine (NECA) or adenosine and 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) (1 nM) gave a 5-fold parallel shift to the right of the concentration-response curves to both CPA and NECA corresponding to an apparent pA2 value of 9.6 suggesting that the agonists relax via adenosine A1 receptors. In the intact ileum adenosine receptor agonists also relaxed the tissue but NECA and CPA were equipotent. DPCPX (3 nM) however inhibited responses to both CPA and NECA with dose-ratios of 8 and 15.6, corresponding to pA2 values of 9.3 and 9.7, respectively. DPCPX (300 nM) gave a much greater shift to the right of the concentration-response curve to NECA with a dose-ratio of 769, corresponding to an apparent pA2 of 9.4. This suggests that the agonists are acting at adenosine A1 receptors to cause relaxation of the whole tissue. Adenosine receptor agonists contracted rat ileal muscularis mucosae with a potency order indicative of an A adenosine receptor. DPCPX (3-100 nM) antagonized responses to CPA giving a linear Schild plot with a slope close to unity and a pA2 of 8.4 suggesting an action on adenosine A1 receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9455996     DOI: 10.1016/s0014-2999(97)81942-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Modulation of the release of endogenous adenosine by cannabinoids in the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum.

Authors:  M Begg; N Dale; E Llaudet; A Molleman; M E Parsons
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Characterization and tissue location of the neural adenosine receptor in the rat ileum.

Authors:  I M Coupar
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  Pretreatment with adenosine and adenosine A1 receptor agonist protects against intestinal ischemia-reperfusion injury in rat.

Authors:  V Haktan Ozacmak; Hale Sayan
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

4.  Purinergic mechanisms in the control of gastrointestinal motility.

Authors:  J C Bornstein
Journal:  Purinergic Signal       Date:  2007-10-06       Impact factor: 3.765

5.  Adenosine negatively regulates duodenal motility in mice: role of A(1) and A(2A) receptors.

Authors:  M G Zizzo; M Mastropaolo; L Lentini; F Mulè; R Serio
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

6.  Pharmacological characterisation of the adenosine receptor mediating increased ion transport in the mouse isolated trachea and the effect of allergen challenge.

Authors:  Kristin N Kornerup; Clive P Page; James D Moffatt
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

7.  Molecular identification and pharmacological characterization of adenosine receptors in the guinea-pig colon.

Authors:  M Kadowaki; M Takeda; K Tokita; K Hanaoka; M Tomoi
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

8.  Inhibitory responses to exogenous adenosine in murine proximal and distal colon.

Authors:  Maria Grazia Zizzo; Flavia Mulè; Rosa Serio
Journal:  Br J Pharmacol       Date:  2006-07-03       Impact factor: 8.739

9.  Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation.

Authors:  Joris G De Man; Tom C Seerden; Benedicte Y De Winter; Eric A Van Marck; Arnold G Herman; Paul A Pelckmans
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 10.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.